Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma

Aberrant expression of the progenitor marker Neuron-glia 2 (NG2/CSPG4) or melanoma proteoglycan on cancer cells and angiogenic vasculature is associated with an aggressive disease course in several malignancies including glioblastoma multiforme (GBM) and melanoma. Thus, we investigated the mechanism...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Wang, Jian, Svendsen, Agnete, Kmiecik, Justyna, Immervoll, Heike, Skaftnesmo, Kai Ove, Planagumà, Jesús, Reed, Rolf Kåre, Bjerkvig, Rolf, Miletic, Hrvoje, Enger, Per Øyvind, Rygh, Cecilie Brekke, Chekenya, Martha
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2011
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3146530/
https://ncbi.nlm.nih.gov/pubmed/21829586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0023062
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller